Recurrent pregnancy loss (RPL) is two or more consecutive miscarriages, and current medical guidelines recommend testing after your second loss rather than waiting for a third. Most cases have an identifiable cause, and many are treatable—but about half of couples never get a clear answer yet still have an excellent chance of a successful pregnancy. Learning that you have recurrent loss can feel like a medical mystery, but testing exists, treatment works for some causes, and the statistics for your next pregnancy are much better than you might fear. This article walks you through which tests to expect, what they look for, and what the answers actually mean for your body and your next pregnancy attempt.
Table of Contents
- Definition, Diagnosis, and When to Seek Testing
- The Testing Approach—What Doctors Look For
- Chromosomal and Genetic Causes—What the Tissue Tests Find
- Structural Uterine Problems That Cause Recurrent Loss
- Blood Clotting Disorders and Immune Causes
- Unexplained Recurrent Pregnancy Loss—When Tests Find Nothing
- When Causes Are Found—Treatments That Actually Work
- Treatments That Don't Help—Avoid False Hope
- Understanding Your Prognosis and Next Steps
- Grieving, Moving Forward, and Support
- Frequently Asked Questions
Definition, Diagnosis, and When to Seek Testing
Recurrent pregnancy loss means two or more consecutive miscarriages that occur before 20 weeks gestation. The term "consecutive" matters: prior losses count only if they were followed by no successful pregnancies between them. If your first two losses were very early (before 10 weeks), talk with your doctor about whether to pursue full testing immediately or observe for a pattern first.
Testing after two losses instead of three means catching treatable causes earlier and not waiting through another pregnancy that might also end. Some conditions, like blood clotting disorders, have specific treatments that work best when started before pregnancy. Other causes, like structural uterine problems, can be fixed before you try again. Early evaluation also gives you answers faster instead of hoping the next pregnancy "just works." Your doctor will recommend evaluation after two consecutive losses in early pregnancy (under 20 weeks).
If you've had a successful pregnancy followed by two later losses, evaluation is still recommended. If one loss was in the second trimester and others earlier, the pattern suggests genetic or anatomical causes worth investigating. Always tell your doctor about all prior losses, including any that occurred before you started prenatal care with them. Recurrent pregnancy loss affects 1-2% of couples trying to conceive.
Single miscarriages are common—roughly 15-25% of recognized pregnancies end in loss—but recurrent loss is far less frequent. The risk rises with maternal age: women over 35 have a higher baseline miscarriage rate, which can make recurrent loss more likely. Previous successful pregnancies don't rule out RPL; some women have healthy children, then later experience recurrent losses.
Seeking testing after loss is not premature or impatient. Two consecutive losses provide enough evidence that something may need investigation. Testing typically takes 4-8 weeks, depending on your doctor's available appointments and lab result timelines. Starting the process early means you'll have answers before you're emotionally and physically ready to try again, so you're not making decisions without knowing your options.
At your first evaluation, your doctor will take a detailed history: When did each loss occur? How far along were you? Did you have bleeding, pain, or other symptoms? They'll ask about your menstrual cycle, any prior pregnancies, and your partner's history. They'll examine you physically and may order initial bloodwork. This gathering of details guides which tests to recommend next.
The Testing Approach—What Doctors Look For
Doctors test for four main categories of causes: genetic/chromosomal problems in the pregnancy tissue, structural abnormalities in your uterus, blood clotting disorders, and immune-related conditions. Not every couple needs every test, but a standard workup includes tissue genetic testing (if tissue is available), uterine imaging, and blood tests for blood-clotting and immune markers.
Testing usually happens over several visits and labs across several weeks. If you have tissue from a loss after 10 weeks, your doctor will usually recommend genetic testing of that tissue—the most important single test. The 2026 ASRM guidelines recommend array-based microarray analysis, which can analyze the majority of samples and identifies chromosomal problems more reliably than older methods, succeeding in over 85% of cases compared to 60% for culture-based karyotyping.
Tissue obtained very early (before 8 weeks) often cannot be tested because not enough fetal cells are present. Your doctor will order imaging of your uterus using ultrasound, hysterosalpingography (X-ray with dye), or sometimes hysteroscopy (looking inside with a camera). These tests check for anatomical problems like a septum (a wall dividing the uterus), fibroids, polyps, or scarring.
Structural problems cause about 10-20% of recurrent loss cases. If an anomaly is found, treatment is often straightforward and improves outcomes significantly. Blood tests screen for conditions that increase miscarriage risk: antiphospholipid antibodies (which affect blood clotting), thyroid disease, and diabetes. Some doctors also test for inherited blood-clotting disorders (thrombophilias). These tests are usually done before you're pregnant so results are clear and not confused by pregnancy's natural effects on blood work and immune function.
Your doctor may suggest genetic testing of you and your partner's blood to check for balanced chromosomal rearrangements—rare variations that usually don't cause problems for the carrier but can cause miscarriage when passed to a pregnancy. This test is recommended if RPL is accompanied by other symptoms or if ethnic background suggests increased risk. Many couples without other risk factors skip this step.
A full testing workup typically takes 2-4 months from start to finish. Microarray tissue analysis takes 1-2 weeks. Blood test results return within days to one week. Ultrasound can often be done within the same month. Insurance usually covers testing for recurrent loss, but copays and out-of-pocket maximums vary by plan. Ask your doctor's office for a cost estimate before testing starts.
If you didn't save tissue from a prior loss or the loss was very early, your doctor can still run blood tests and uterine imaging. These tests will identify some causes (like structural problems or blood-clotting disorders) but not chromosomal issues in the pregnancy tissue. If you're planning another pregnancy attempt, genetic testing of the tissue can happen in advance if that next pregnancy also ends in loss.
Chromosomal and Genetic Causes—What the Tissue Tests Find
Array-based microarray analysis looks at all 23 pairs of chromosomes in fetal tissue and checks whether the number is correct (normal = two copies of each chromosome) and whether large sections are missing or duplicated. The test is successful in analyzing roughly 85% of tissue samples, compared to 60% for older karyotyping methods. When the test works, it reliably identifies chromosomal problems.
In about 40-60% of successfully analyzed tissue, microarray identifies a chromosomal abnormality. The most common findings are aneuploidy (too many or too few whole chromosomes) like Trisomy 13, 16, 18, or 21, or Monosomy X (missing one X chromosome). Many of these abnormalities are incompatible with life and cause miscarriage in early pregnancy. Finding a chromosomal problem in the tissue often provides the answer: sometimes it was "just" a random genetic error, not a sign of a future problem.
About 15-25% of tissue samples fail to produce results despite proper handling. Failure usually means the tissue was too scarce, was contaminated with maternal cells, or died during processing. A failed sample is frustrating but doesn't mean your doctors won't get answers—it just means they'll rely more heavily on blood tests, imaging, and chromosome testing of you and your partner.
If another loss occurs, you can try tissue testing again. Most couples with a chromosomal abnormality in one miscarriage will not see the same abnormality again. However, some couples carry a rearrangement that predisposes them to repeated losses, especially if both partners carry a balanced translocation. This is rare and is found through blood testing of the parents, not tissue analysis.
If your partner carries a rearrangement, genetic counseling helps you weigh your options. If tissue testing shows normal chromosomes, your loss was not due to a genetic problem the test can detect. This is actually good news: it means either a non-chromosomal cause (which may be treatable) or an unknown cause with a favorable prognosis for your next pregnancy.
A normal tissue result is the most common finding and often leads your doctor to focus on other tests—blood work and uterine imaging—to find a specific cause. Tissue from a loss before 8 weeks is often largely maternal tissue, not fetal tissue, so microarray may not work. Tissue from losses after 10 weeks usually contains enough fetal cells for testing to succeed. If you're planning to try again and concerned about recurrent loss, discuss with your doctor how to preserve tissue from any future loss right away so testing can happen quickly.
Structural Uterine Problems That Cause Recurrent Loss
About 10-20% of women with recurrent pregnancy loss have a structural abnormality in their uterus. These problems range from congenital anomalies (present at birth) like a septum or bicornuate uterus, to acquired problems like fibroids, polyps, or scarring from prior surgery. Many structural problems are correctable with surgery, and fixing them significantly improves pregnancy outcomes.
A uterine septum is a wall of tissue that partially divides the uterine cavity, essentially creating two chambers instead of one. It's the most common congenital uterine anomaly. Women with an untreated septum have a miscarriage rate around 41%, versus 12% in women without a septum. The good news: a septum is readily identified on ultrasound and easily removed by hysteroscopic surgery, after which miscarriage rates drop significantly.
Other structural anomalies include a bicornuate uterus (two-horned uterus), unicornuate uterus (one horn), uterine agenesis, and didelphys uterus (two separate uteri). These are less common than septum. Bicornuate uterus is sometimes managed with expectant care because the pregnancy can still implant and develop normally. Other anomalies may require specialist consultation with a reproductive endocrinologist to plan the safest approach.
Uterine fibroids (noncancerous muscle growths) and polyps (tissue overgrowths) can interfere with implantation and blood flow to the pregnancy. Large fibroids distorting the uterine cavity or polyps in the main cavity are usually removed. Fibroids don't always require removal; the location and size matter. Your doctor can assess whether a specific fibroid or polyp is likely contributing to your losses.
Scarring inside the uterus (Asherman syndrome) can result from dilation and curettage (D&C) after a miscarriage or termination, or from untreated infections. Adhesions between the uterine walls reduce the space for a pregnancy to implant and grow normally. Hysteroscopic lysis (cutting the adhesions) restores normal uterine cavity, though scarring sometimes recurs and may need repeated treatment.
If a uterine septum or other structural problem is identified, the treatment is hysteroscopic surgery: your doctor uses a camera (hysteroscope) and small instruments to carefully divide the septum or remove fibroids and polyps. The procedure takes 30-60 minutes, is often done as same-day surgery, and requires minimal recovery time. After healing (usually 1-2 months), you're cleared to try again.
Blood Clotting Disorders and Immune Causes
Antiphospholipid syndrome (APS) is a blood-clotting disorder in which your immune system makes antibodies that increase clotting, raising the risk of miscarriage, especially in the second trimester. About 25% of women with recurrent pregnancy loss test positive for antiphospholipid antibodies. The good news: APS is identifiable through blood tests and is very treatable before and during pregnancy.
APS damages the placenta by triggering blood clots in the placental vessels, reducing oxygen and nutrient flow to the fetus. This happens unpredictably; some pregnancies affected by APS do fine, while others miscarry in the second trimester. Early detection and treatment prevent these clotting events. If you test positive for antiphospholipid antibodies, don't panic—treatment is effective and evidence-based.
Your doctor will order blood tests for two types of antiphospholipid antibodies: lupus anticoagulant and anticardiolipin antibodies. Testing is done when you're not pregnant, so results are clear. A single positive test result doesn't confirm APS; antibodies must be present on repeat testing at least 12 weeks later to meet diagnostic criteria. Some women have transiently positive tests that don't persist.
The first-line treatment for APS in pregnancy is a combination of low-dose aspirin started before pregnancy (81 mg daily) and unfractionated heparin injections during pregnancy. Studies show that women with APS antibodies treated with aspirin and heparin achieve live birth in about 79% of pregnancies, compared to 62% with aspirin alone.
Heparin is given as daily injections; dosing depends on your weight and clotting risk. Inherited thrombophilias (like Factor V Leiden or prothrombin gene mutation) are more common in women with recurrent loss than in the general population, but they're also common in women without miscarriage. The decision to test for inherited clotting disorders and to treat them in pregnancy depends on your doctor's assessment.
Low-molecular-weight heparin may be offered in pregnancy if you carry a strong thrombophilia. Blood tests also screen for thyroid disease (especially hypothyroidism) and inadequately controlled diabetes, both linked to recurrent loss. Thyroid dysfunction is easily treated with medication, and optimizing blood sugar control before pregnancy significantly improves outcomes. These conditions are important to identify early because treatment is simple and effective.
Unexplained Recurrent Pregnancy Loss—When Tests Find Nothing
After complete testing—tissue analysis, uterine imaging, blood tests for antibodies and thyroid disease, and sometimes chromosome testing—50-60% of couples still have no identified cause. This doesn't mean something is wrong with the testing or that your doctors have given up. It means that despite their efforts, no clear explanation emerges. Unexplained RPL is actually very common.
"Unexplained" doesn't mean random or hopeless. It means your doctors have ruled out the major known categories of recurrent loss—chromosomal, structural, immune, infectious, and metabolic. There may be causes that medicine doesn't yet fully understand, or factors that are harder to measure, or even bad luck. But none of this changes your prognosis for the next pregnancy, which is actually quite good.
For couples with unexplained recurrent loss, 65-85% achieve a live birth in their next pregnancy attempt, even without specific treatment. Having two, three, or more prior unexplained losses slightly lowers these odds, but the majority still go on to have successful pregnancies. If you had at least one loss with normal chromosomes, your odds trend even slightly higher.
Hearing "unexplained" after testing can feel anticlimactic or dismissive, but it actually often carries good news. It means no genetic rearrangement threatens your future pregnancies, no uterine surgery is needed, and no long-term medication is mandatory. Many couples with unexplained losses feel initially disappointed, then relieved when they understand the favorable odds for the next attempt.
After a diagnosis of unexplained RPL and a period of physical and emotional healing, many couples try again. Some doctors recommend waiting 3-6 months to allow full physical recovery and to let grief soften. There's no absolute "right time," but having processing space between losses often helps couples approach a new pregnancy with less anxiety.
Talk with your partner and your doctor about what feels right for you. If your next pregnancy is wanted, your doctor may recommend more frequent early ultrasounds or earlier prenatal visits than typical. Seeing a heartbeat, confirming dates, and reaching 12 weeks (when miscarriage risk drops substantially) often provides psychological reassurance. Some patients find close monitoring comforting; others find it anxiety-provoking. Discuss with your doctor what support will serve you best.
When Causes Are Found—Treatments That Actually Work
When testing identifies a specific cause, treatment usually improves outcomes significantly. If a uterine septum is removed, miscarriage rates drop from 41% to 12-15%. If antiphospholipid antibodies are found and treated with aspirin and heparin, live birth rates rise to 79%. These gains make testing and treatment worthwhile, even if they require time, surgery, or medication during pregnancy.
If a uterine septum is identified, the treatment is hysteroscopic septal resection: a minimally invasive surgery where your doctor uses a camera and small instruments to carefully divide the septum. The procedure takes 30-60 minutes, is often done as same-day surgery, and requires minimal recovery. After healing (usually 1-2 months), you're cleared to try again.
Success rates for live birth after resection are 60-80% in subsequent pregnancies. Fibroids distorting the cavity or polyps are removed hysteroscopically, similar to septal resection. Recovery is quick. After fibroid removal, miscarriage risk is reduced if the fibroid was causing implantation problems. Some fibroids don't interfere with pregnancy and can be left alone; your doctor will advise whether removal is necessary based on size, location, and your symptoms.
If adhesions are found, hysteroscopic lysis separates the scarred areas, restoring normal uterine cavity. The procedure can sometimes be followed by estrogen therapy or insertion of a balloon or device to keep the cavity open during healing. Recovery is typically quick, though adhesions sometimes recur. Pregnancy rates after lysis improve substantially. Women diagnosed with antiphospholipid antibodies take low-dose aspirin (81 mg) daily starting before pregnancy attempt or immediately upon positive pregnancy test.
Once pregnant, unfractionated heparin injections (subcutaneous, usually twice daily) are started. The combination reduces placental clotting and significantly improves live birth rates. Heparin is continued throughout pregnancy and postpartum. If hypothyroidism is found, thyroid replacement medication is started and doses adjusted until thyroid levels normalize. If diabetes is present, blood sugar control is optimized, ideally before pregnancy.
These conditions are highly treatable, and treatment prevents miscarriage. Starting treatment before pregnancy is preferred so medication is stable when you conceive. If chromosome testing reveals you or your partner carry a balanced translocation (a rearrangement that predisposes to unbalanced pregnancies), genetic counseling is important. A genetic counselor will explain your risks, discuss options like preimplantation genetic testing (PGT) if pursuing fertility treatment, and help you weigh your choices.
Treatments That Don't Help—Avoid False Hope
Progesterone is a hormone that maintains the uterine lining and is often used in pregnancy to prevent preterm birth. Many women with recurrent loss have heard that progesterone might prevent miscarriage, and it's tempting to hope. However, large randomized trials found that first-trimester progesterone did not increase live birth rates in women with unexplained recurrent loss (65.8% with progesterone vs. 63.3% with placebo).
Progesterone is not routinely recommended for unexplained RPL. Progesterone might be appropriate if you have a short cervix in early pregnancy (a sign of cervical insufficiency) or if you conceive after fertility treatment. In these specific situations, progesterone is evidence-based. But for routine unexplained recurrent loss, starting it as a preventive is not supported by research and can create false hope.
Intravenous immunoglobulin (IVIG) is an immune-modulating treatment sometimes discussed for recurrent loss, based on a theory that immune dysregulation contributes to miscarriage. However, meta-analyses of studies comparing IVIG to placebo show no significant benefit. IVIG is expensive, requires infusions, and carries small risks of its own. It is not routinely recommended for unexplained RPL. Other treatments sometimes offered for recurrent loss include intralipid (fat emulsion), steroids, antibiotics (without infection), and various supplements.
None of these have strong evidence supporting their use in unexplained recurrent loss. If a doctor recommends any of these, ask for the evidence and consider getting a second opinion from a reproductive endocrinologist. Low-dose aspirin is very beneficial for women with antiphospholipid antibodies, but it does not improve outcomes in unexplained recurrent loss without those antibodies.
Taking aspirin "just in case" doesn't prevent miscarriage in unexplained cases, though it carries low risk. Your doctor can advise whether it's worth trying given your situation, but it's not standard treatment. Many websites and ads promote supplements, herbs, or "natural" treatments for recurrent loss. Few have rigorous evidence. Prenatal vitamins with folic acid are recommended for all women planning pregnancy, and some nutrients (like vitamin D) are under study. But expecting a supplement to prevent recurrent loss without evidence is risky—it delays effective treatment if a cause is found.
Understanding Your Prognosis and Next Steps
After recurrent pregnancy loss, the data on your next pregnancy is hopeful. Even with unexplained losses and no specific treatment, 65-85% of couples achieve live birth in the next pregnancy. Prior losses reduce odds slightly, but they don't reverse them. If testing identifies a treatable cause, outcomes improve further. Statistically, your chances of success in your next attempt are greater than your chances of another loss.
Maternal age affects baseline miscarriage risk. Women under 30 have roughly a 10% miscarriage rate per pregnancy; women over 40 have roughly 40-50%. If you're in your 20s with recurrent loss, the good news is your age is in your favor for the next attempt. If you're over 40, outcomes are still positive but slightly lower.
Age is one factor among many; it doesn't define your story. Some women with recurrent loss had a successful pregnancy before the losses started. This is a favorable sign: it shows your body can carry a pregnancy. But a history of one successful pregnancy followed by two losses means RPL evaluation is still warranted and recommended.
A previous success doesn't rule out a currently treatable cause like a uterine problem or blood disorder. If your losses were spread over years, you might wonder whether spacing out your next attempt matters. Research doesn't strongly support waiting years between losses to "reset" your body—waiting months is usually enough. Six months to a year allows physical healing and emotional recovery.
Whether you try again in 6 months or 18 months, your odds of success don't depend heavily on that timeline. Once testing is complete and any identified problems are treated, planning your next pregnancy usually proceeds as it would for any couple. If you're trying naturally, having regular intercourse around your ovulation window is the foundation.
If you're considering fertility treatment (like IVF), discuss with your doctor whether it's recommended in your situation, especially if testing revealed a genetic rearrangement. Organizations like RESOLVE (the infertility association) and the Miscarriage Association offer support groups, counseling referrals, and communities of others who've experienced recurrent loss. Talking with others who've been through RPL and gone on to have babies can be reassuring.
Your doctor can also refer you to a therapist experienced with pregnancy loss. If you become pregnant after testing for recurrent loss, there's usually no need to repeat testing unless the pregnancy fails again at a different gestational week or under different circumstances. If you conceive again and lose at a later week than your prior losses, or with new symptoms, additional investigation may be warranted. Talk with your doctor about your plan going forward.
Grieving, Moving Forward, and Support
Recurrent pregnancy loss is a real loss, regardless of when in pregnancy it occurred. Grief, anger, fear, and sadness are normal responses, especially after multiple losses. Taking time to process your emotions and feel supported is important before, during, or after pursuing another pregnancy attempt. There's no "right" timeline for grief, and your feelings are valid.
Many people after recurrent loss find that anxiety peaks in early pregnancy—especially at the gestation where prior losses occurred. Knowing this anxiety is normal helps. Early reassurance ultrasounds, frequent contact with your doctor, and telling trusted people about your history can all help. Some people find therapy or support groups invaluable during the next pregnancy.
Recurrent pregnancy loss can threaten your sense of identity if you've focused heavily on motherhood. It's okay to grieve what you didn't get. At the same time, exploring who you are and what brings meaning beyond pregnancy—whether through work, relationships, hobbies, or community—can sustain you through the waiting and trying. Some couples, after recurrent loss, decide not to try again and pursue other paths like adoption, foster care, or child-free living.
Others continue trying after testing and treatment. There's no universally "right" decision. What matters is that the choice aligns with your values, your partner's values, and your capacity for emotional and physical challenge. A good reproductive endocrinologist or OB-GYN listens to your concerns, explains the evidence clearly, doesn't rush you into decisions, and supports whatever you choose.
If you feel dismissed or pressured, seeking a second opinion is reasonable. You deserve a doctor who sees you as a full person, not just a set of numbers and test results. Recurrent pregnancy loss is painful, but it's treatable for many causes and carries a favorable outlook for most. Testing provides answers or, if no specific cause emerges, reassurance that future pregnancy odds are good. You're not alone, your feelings are valid, and medical evidence supports cautious hope as you move forward.
Frequently Asked Questions
When should I get testing for recurrent miscarriage?
Current guidelines recommend evaluation after two consecutive losses, not three. Talk with your doctor right after your second loss to begin the process.
What is the most important test for recurrent pregnancy loss?
Genetic testing of miscarriage tissue (microarray) is the cornerstone test. It identifies chromosomal problems in about 40–60% of samples that successfully analyze.
What does it mean if my uterine ultrasound is normal?
A normal ultrasound rules out structural problems like septum, fibroids, or polyps and is excellent news. About 80–90% of people with recurrent loss have normal uterine anatomy.
Can I do anything to prevent another miscarriage?
It depends on your diagnosis. Treating identified causes (like antiphospholipid antibodies with aspirin and heparin, or uterine septum with surgery) significantly improves outcomes. For unexplained loss, no single treatment is proven effective.
What if all my tests come back normal?
Normal tests mean no identified treatable cause was found—but they're actually reassuring. 65–85% of couples with unexplained recurrent loss go on to have successful next pregnancies without specific treatment.
Does progesterone prevent miscarriage?
For unexplained recurrent loss, large clinical trials found progesterone did not improve live birth rates compared to placebo. It's not routinely recommended for RPL prevention.
